```html

Melanoma (Skin Spot)

What is Melanoma (skin spot)?

Melanoma is a malignant tumor that arises from melanocytes, the pigment‑producing cells found in the basal layer of the skin. Although it accounts for less than 5 % of all skin cancers, it causes the majority of skin‑cancer‑related deaths because it can spread (metastasize) quickly if not detected early.

When patients notice a new or changing pigmented spot on their skin, they often refer to it simply as a “skin spot.” A melanoma‑type spot typically shows irregular borders, uneven color, and a diameter larger than 6 mm (about the size of a pencil eraser), but it can be smaller or larger. Early identification and treatment are crucial for a favorable prognosis.

Key points:

• Most common in adults 25–55 years old but can occur at any age.
• Higher incidence in people with fair skin, many moles, or a family history of skin cancer.
• UV radiation (sunlight or tanning beds) is the primary environmental risk factor.

Sources: Mayo Clinic, Melanoma Overview; WHO, Melanoma Fact Sheet.

Common Causes

Melanoma itself is a disease, but several underlying conditions or risk factors increase the likelihood of developing a malignant skin spot. Below are the most important contributors:

• Excessive ultraviolet (UV) exposure – both natural sunlight and artificial sources (tanning beds).
• Fair skin, red or blond hair, blue/green eyes – reduced melanin provides less natural protection.
• Family history of melanoma – genetic mutations (e.g., CDKN2A, BRAF) raise risk.
• Personal history of atypical (dysplastic) nevi – irregularly shaped moles that look different from ordinary moles.
• Presence of many common moles – having >50 moles increases risk.
• Immunosuppression – organ‑transplant recipients, HIV infection, or long‑term corticosteroid use.
• History of severe sunburns, especially in childhood.
• Certain genetic syndromes – e.g., xeroderma pigmentosum, familial atypical multiple mole melanoma (FAMMM) syndrome.
• Exposure to carcinogenic chemicals – arsenic, polycyclic aromatic hydrocarbons (found in some industrial settings).
• Chronic skin injury or scarring – rare cases of melanoma can arise in long‑standing scars or chronic ulcers.

Associated Symptoms

While many melanomas are initially painless, they are often accompanied by the following findings:

• Changes in the size, shape, or color of an existing mole.
• Bleeding, oozing, or crusting on the spot.
• Itching or tenderness around the lesion.
• Surface elevation – the spot feels raised or develops a “bump.”
• Development of new pigmented lesions that differ from surrounding skin.
• Satellite lesions – smaller dark spots near the main lesion, suggesting spread.

Advanced melanoma may produce systemic symptoms such as unexplained weight loss, fatigue, or swollen lymph nodes.

When to See a Doctor

Prompt evaluation is essential. Seek medical attention if you notice any of the following, often remembered by the ABCDE rule:

• A – Asymmetry: One half does not match the other.
• B – Border irregularity: Jagged, scalloped, or poorly defined edges.
• C – Color variation: Multiple shades of brown, black, tan, red, white, or blue.
• D – Diameter: Larger than 6 mm (pencil‑eraser size) or any size that is growing.
• E – Evolution: Any change over weeks or months, including new symptoms like bleeding.

Additional red flags warrant urgent evaluation:

• Rapid growth within days.
• Persistent ulceration or non‑healing sore.
• New lesion on the palms, soles, or under the nails (subungual melanoma).

If you fall into any of these categories, schedule an appointment with a dermatologist or primary‑care provider promptly. Early excision can be curative.

Diagnosis

Diagnosing melanoma involves a step‑wise approach that combines visual assessment, dermatoscopic examination, and tissue analysis.

1. Clinical Examination

The clinician will perform a full‑body skin check, documenting any suspicious lesions and comparing them with prior photographs or exam records.

2. Dermatoscopy (Dermatoscope)

A handheld magnifying device that reveals patterns invisible to the naked eye. Features such as atypical network, streaks, or blue‑white veil help differentiate melanoma from benign nevi.

3. Biopsy

The definitive diagnosis requires a tissue sample. Common techniques include:

• Excisional biopsy: Entire lesion removed with a narrow margin; preferred for lesions ≤ 2 cm.
• Punch or shave biopsy: Used for larger or more difficult‑to‑remove areas, though may be less accurate for depth assessment.

The specimen is sent to a pathology lab for histologic evaluation.

4. Histopathology

Pathologists assess melanoma thickness using the Breslow depth (in millimeters) and ulceration status—both critical for staging.

5. Staging Work‑up (if invasive)

• Sentinel lymph‑node biopsy (SLNB) for tumors >0.8 mm thickness or with high‑risk features.
• Imaging (CT, PET/CT, MRI) if there is suspicion of metastasis.

6. Molecular Testing

Advanced centers may test for BRAF, NRAS, or c‑KIT mutations, which guide targeted therapy decisions.

Treatment Options

Treatment depends on the stage, location, and molecular profile of the melanoma. Below is a tiered overview.

1. Surgical Management

• Wide local excision: Removal of the tumor with a 1–2 cm margin of normal tissue (wider for thicker lesions).
• Sentinel lymph‑node biopsy (SLNB): Determines microscopic spread to regional nodes.
• Complete lymph‑node dissection: Performed if SLNB is positive, though recent trials suggest observation may be acceptable in selected patients.

2. Adjuvant Therapies (after surgery)

• Immunotherapy: Checkpoint inhibitors such as nivolumab, pembrolizumab, or the combination ipilimumab + nivolumab have dramatically improved survival for stage III/IV disease.
• Targeted therapy: For BRAF‑mutated melanomas (≈ 40 % of cases), combination BRAF inhibitors (vemurafenib, dabrafenib) plus MEK inhibitors (trametinib, cobimetinib) are standard.
• Interferon‑alpha: Historically used as adjuvant therapy; now largely replaced by newer agents but still an option in certain settings.

3. Systemic Therapy for Advanced Disease

• Monotherapy or combination checkpoint inhibitors.
• BRAF/MEK targeted combos for mutation‑positive tumors.
• Oncolytic virus therapy (talimogene laherparepvec – T‑VEC) for injectable lesions.
• Enrollment in clinical trials – recommended whenever feasible.

4. Radiation Therapy

Used for unresectable local disease, brain metastases, or palliation of symptomatic lesions.

5. Home & Supportive Care

• Wound care after excision – keep the site clean, dry, and follow suturing instructions.
• Sun protection to prevent new lesions.
• Psychosocial support – counseling, support groups, and survivorship programs.
• Regular skin self‑exams and scheduled dermatologist visits.

Prevention Tips

While genetics cannot be changed, most melanomas are linked to UV exposure, which is modifiable.

• Use broad‑spectrum sunscreen with SPF 30 or higher; reapply every two hours and after swimming or sweating.
• Seek shade between 10 a.m. and 4 p.m., when UV rays are strongest.
• Wear protective clothing – long‑sleeved shirts, wide‑brim hats, and UV‑protective sunglasses.
• Avoid indoor tanning – tanning beds emit concentrated UV‑A and UV‑B radiation.
• Perform monthly skin self‑exams and keep a photo log of moles.
• Schedule annual skin exams with a dermatologist, especially if you have risk factors.
• Educate children early about sun safety to reduce lifetime cumulative UV exposure.
• Take vitamin D responsibly – obtain it from diet or supplements rather than excessive sun exposure.

Emergency Warning Signs

Key Takeaways

Melanoma is a potentially deadly skin cancer that often begins as a seemingly innocuous spot. Recognizing the ABCDE warning signs, understanding personal risk factors, and acting quickly when changes occur dramatically improve outcomes. Modern treatments—including surgery, immunotherapy, and targeted drugs—have turned many advanced cases into manageable chronic conditions, but prevention and early detection remain the most powerful tools.

For further reading, consult reputable sources such as the CDC Skin Cancer Center, NIH National Cancer Institute, and the Cleveland Clinic Melanoma Guide.

```